Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Reed

Showing results (71-80 of 263) with videos related to

Pageof 27
Sort By:
Tuberculosis (Edinburgh, Scotland)|February 22, 2012
BCG: myths, realities, and the need for alternative vaccine strategiesHelen McShane, William R Jacobs, Paul E Fine, et al.
Clinical and Vaccine Immunology : CVI|December 24, 2010
Insight toward early diagnosis of leprosy through analysis of the developing antibody responses of Mycobacterium leprae-infected armadillosMalcolm S Duthie, Richard W Truman, Wakako Goto, et al.
Plos One|January 6, 2016
The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for TH1 InductionNatasha Dubois Cauwelaert, Anthony L Desbien, Thomas E Hudson, et al.
Trends in Microbiology|October 16, 2002
Taking toll: lipid A mimetics as adjuvants and immunomodulatorsDavid H Persing, Rhea N Coler, Michael J Lacy, et al.
AMB Express|August 2, 2020
The single recombinant M. tuberculosis protein DPPD provides enhanced performance of skin testing among HIV-infected tuberculosis patientsRoberto Badaro, Bruna A S Machado, Malcolm S Duthie, et al.
Infection and Immunity|February 19, 2015
Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoesKailash P Patra, Fengwu Li, Darrick Carter, et al.
Journal of Clinical Microbiology|January 31, 2014
Rapid quantitative serological test for detection of infection with Mycobacterium leprae, the causative agent of leprosyMalcolm S Duthie, Marivic F Balagon, Armi Maghanoy, et al.
Vaccine|May 30, 2015
Gaps in knowledge and prospects for research of adjuvanted vaccinesRobert Seder, Steven G Reed, Derek O'Hagan, et al.
Tuberculosis (Edinburgh, Scotland)|December 4, 2013
Therapeutic vaccination against relevant high virulence clinical isolates of Mycobacterium tuberculosisCrystal A Shanley, Gregory C Ireton, Susan L Baldwin, et al.
Plos One|January 10, 2014
A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93Mark T Orr, Elyse A Beebe, Thomas E Hudson, et al.
Pageof 27

Showing results (71-80 of 263) with videos related to

Sort By:
Pageof 27
Tuberculosis (Edinburgh, Scotland)|February 22, 2012
BCG: myths, realities, and the need for alternative vaccine strategiesHelen McShane, William R Jacobs, Paul E Fine, et al.
Clinical and Vaccine Immunology : CVI|December 24, 2010
Insight toward early diagnosis of leprosy through analysis of the developing antibody responses of Mycobacterium leprae-infected armadillosMalcolm S Duthie, Richard W Truman, Wakako Goto, et al.
Plos One|January 6, 2016
The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for TH1 InductionNatasha Dubois Cauwelaert, Anthony L Desbien, Thomas E Hudson, et al.
Trends in Microbiology|October 16, 2002
Taking toll: lipid A mimetics as adjuvants and immunomodulatorsDavid H Persing, Rhea N Coler, Michael J Lacy, et al.
AMB Express|August 2, 2020
The single recombinant M. tuberculosis protein DPPD provides enhanced performance of skin testing among HIV-infected tuberculosis patientsRoberto Badaro, Bruna A S Machado, Malcolm S Duthie, et al.
Infection and Immunity|February 19, 2015
Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoesKailash P Patra, Fengwu Li, Darrick Carter, et al.
Journal of Clinical Microbiology|January 31, 2014
Rapid quantitative serological test for detection of infection with Mycobacterium leprae, the causative agent of leprosyMalcolm S Duthie, Marivic F Balagon, Armi Maghanoy, et al.
Vaccine|May 30, 2015
Gaps in knowledge and prospects for research of adjuvanted vaccinesRobert Seder, Steven G Reed, Derek O'Hagan, et al.
Tuberculosis (Edinburgh, Scotland)|December 4, 2013
Therapeutic vaccination against relevant high virulence clinical isolates of Mycobacterium tuberculosisCrystal A Shanley, Gregory C Ireton, Susan L Baldwin, et al.
Plos One|January 10, 2014
A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93Mark T Orr, Elyse A Beebe, Thomas E Hudson, et al.
Pageof 27